Monopar Appoints Jeffrey D. Kent, M.D., As Executive Vice President, Head Of Medical Affairs Announces Two Alxn1840 Presentations At AASLD – The Liver Meeting 2026
MNPR•Monopar announces medical affairs appointment and ALXN1840 presentations
Aug. 19 (Reuters) - Monopar Therapeutics Inc. (MNPR.O):
- Monopar appoints Jeffrey D. Kent, M.D., as executive vice president, head of medical affairs; announces two ALXN1840 presentations at AASLD – The Liver Meeting® 2026.
Related News
Marti Q2 revenue jumps 141% as subscription packages scale, management says
MRT•
Skk Holdings Awarded Six New Horizontal Directional Drilling And Utility Works Contracts In Singapore Valued At Up To Us$26.6 Million (S$34.1 Million)
SKK•
